Clinical trials for B-cell prolymphocytic leukemia
4 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 1NCT05418088Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid MalignanciesSumithira Vasu · PI: Sumithira Vasu, MD
- ACTIVE NOT RECRUITINGPhase 1NCT02153580Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic LeukemiaCity of Hope Medical Center · PI: Tanya Siddiqi
- ACTIVE NOT RECRUITINGPhase 2NCT02007044Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaM.D. Anderson Cancer Center · PI: Jan A Burger
- ACTIVE NOT RECRUITINGPhase 2NCT01589302PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic LeukemiaKami Maddocks, MD · PI: Kami Maddocks, MD